A detailed history of Integrated Advisors Network LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Integrated Advisors Network LLC holds 5,381 shares of EXAS stock, worth $309,299. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,381
Previous 5,271 2.09%
Holding current value
$309,299
Previous $222,000 64.86%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$42.43 - $70.83 $4,667 - $7,791
110 Added 2.09%
5,381 $366,000
Q2 2024

Aug 09, 2024

BUY
$41.33 - $74.26 $59,184 - $106,340
1,432 Added 37.3%
5,271 $222,000
Q1 2024

May 03, 2024

SELL
$56.27 - $73.77 $87,668 - $114,933
-1,558 Reduced 28.87%
3,839 $265,000
Q4 2023

Feb 26, 2024

BUY
$59.06 - $75.72 $62,898 - $80,641
1,065 Added 24.58%
5,397 $399,000
Q3 2023

Nov 16, 2023

BUY
$65.94 - $99.04 $16,089 - $24,165
244 Added 5.97%
4,332 $295,000
Q2 2023

Jul 14, 2023

SELL
$62.68 - $95.05 $29,459 - $44,673
-470 Reduced 10.31%
4,088 $383,000
Q1 2023

May 05, 2023

SELL
$47.19 - $70.77 $6,417 - $9,624
-136 Reduced 2.9%
4,558 $309,000
Q4 2022

Feb 02, 2023

BUY
$30.35 - $53.15 $142,462 - $249,486
4,694 New
4,694 $232,000
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $120,148 - $257,200
-3,374 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$57.56 - $82.54 $26,074 - $37,390
-453 Reduced 11.84%
3,374 $236,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $42,340 - $58,797
584 Added 18.01%
3,827 $298,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $292,648 - $402,294
3,243 New
3,243 $310,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.